Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Operational impact of decreased turnaround times for Candida auris screening tests in a tertiary academic medical center
by
Warde, Prem R.
, Gershengorn, Hayley B.
, Pagan, Paola P.
, Patel, Samira
, Parekh, Dipen J.
, Arenas, Sebastian
, Zhou, Yi
, Shukla, Bhavarth S.
, Tamrakar, Labu J.
, Seely, Spencer O.
, Ferreira, Tanira
in
Catheters
/ Cost control
/ Cost reduction
/ COVID-19
/ Disease control
/ Disease transmission
/ Fungal infections
/ Hospitalization
/ Hospitals
/ Inpatient care
/ Length of stay
/ Medical laboratories
/ Medical screening
/ Ostomy
/ Pandemics
/ Pathogens
/ Patients
/ Regression analysis
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Operational impact of decreased turnaround times for Candida auris screening tests in a tertiary academic medical center
by
Warde, Prem R.
, Gershengorn, Hayley B.
, Pagan, Paola P.
, Patel, Samira
, Parekh, Dipen J.
, Arenas, Sebastian
, Zhou, Yi
, Shukla, Bhavarth S.
, Tamrakar, Labu J.
, Seely, Spencer O.
, Ferreira, Tanira
in
Catheters
/ Cost control
/ Cost reduction
/ COVID-19
/ Disease control
/ Disease transmission
/ Fungal infections
/ Hospitalization
/ Hospitals
/ Inpatient care
/ Length of stay
/ Medical laboratories
/ Medical screening
/ Ostomy
/ Pandemics
/ Pathogens
/ Patients
/ Regression analysis
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Operational impact of decreased turnaround times for Candida auris screening tests in a tertiary academic medical center
by
Warde, Prem R.
, Gershengorn, Hayley B.
, Pagan, Paola P.
, Patel, Samira
, Parekh, Dipen J.
, Arenas, Sebastian
, Zhou, Yi
, Shukla, Bhavarth S.
, Tamrakar, Labu J.
, Seely, Spencer O.
, Ferreira, Tanira
in
Catheters
/ Cost control
/ Cost reduction
/ COVID-19
/ Disease control
/ Disease transmission
/ Fungal infections
/ Hospitalization
/ Hospitals
/ Inpatient care
/ Length of stay
/ Medical laboratories
/ Medical screening
/ Ostomy
/ Pandemics
/ Pathogens
/ Patients
/ Regression analysis
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Operational impact of decreased turnaround times for Candida auris screening tests in a tertiary academic medical center
Journal Article
Operational impact of decreased turnaround times for Candida auris screening tests in a tertiary academic medical center
2023
Request Book From Autostore
and Choose the Collection Method
Overview
Objective:Assess turnaround time (TAT) and cost-benefit of on-site C. auris screening and its impact on length of stay (LOS) and costs compared to reference laboratories.Design:Before-and-after retrospective cohort study.Setting:Large-tertiary medical center.Methods:We validated an on-site polymerase chain reaction-based testing platform for C. auris and retrospectively reviewed hospitalized adults who screened negative before and after platform implementation. We constructed multivariable models to assess the association of screening negative with hospital LOS/cost in the pre and postimplementation periods. We adjusted for confounders such as demographics and indwelling device use, and compared TATs for all samples tested.Results:The sensitivity and specificity of the testing platform were 100% and 98.11%, respectively, compared to send-out testing. The clinical cohort included 287 adults in the pre and 1,266 postimplementation period. The TAT was reduced by more than 2 days (3 (interquartile range (IQR): 2.0, 7.0) vs 0.42 (IQR: 0.24, 0.81), p < 0.001). Median LOS was significantly lower in the postimplementation period; however, this was no longer evident after adjustment. In relation to total cost, the time period had an effect of $6,965 (95% CI: −$481, $14,412); p = 0.067) on reducing the cost. The median adjusted total cost per patient was $7,045 (IQR: $3,805, $13,924) less in the post vs the preimplementation period.Conclusions:Our assessment did not find a statistically significant change in LOS, nevertheless, on-site testing was not cost-prohibitive for the institution. The value of on-site testing may be supported if an institutional C. auris reduction strategy emphasizes faster TATs.
Publisher
Cambridge University Press
Subject
This website uses cookies to ensure you get the best experience on our website.